Showing results (1-10 of 24) with videos related to
Sort By:
Pageof 3
Annals of the New York Academy of Sciences|April 5, 2013
Role of SHIP1 in cancer and mucosal inflammationSandra Fernandes, Sonia Iyer, William G KerrAnnals of the New York Academy of Sciences|April 5, 2013
Role of SHIP1 in bone biologySonia Iyer, Bryan S Margulies, William G KerrStem Cells and Development|December 20, 2014
SHIP1-expressing mesenchymal stem cells regulate hematopoietic stem cell homeostasis and lineage commitment during agingSonia Iyer, Robert Brooks, Matthew Gumbleton, et al.Stem Cells and Development|May 27, 2014
SHIP1 regulates MSC numbers and their osteolineage commitment by limiting induction of the PI3K/Akt/β-catenin/Id2 axisSonia Iyer, Dennis R Viernes, John D Chisholm, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 5, 2010
SHIP1 inhibition increases immunoregulatory capacity and triggers apoptosis of hematopoietic cancer cellsRobert Brooks, Gwenny M Fuhler, Sonia Iyer, et al.JCI Insight|August 19, 2016
A small-molecule inhibitor of SHIP1 reverses age- and diet-associated obesity and metabolic syndromeNeetu Srivastava, Sonia Iyer, Raki Sudan, et al.Molecular Medicine (Cambridge, Mass.)|October 29, 2011
Therapeutic potential of SH2 domain-containing inositol-5'-phosphatase 1 (SHIP1) and SHIP2 inhibition in cancerGwenny M Fuhler, Robert Brooks, Bonnie Toms, et al.Bioengineering & Translational Medicine|March 17, 2023
Layer-by-layer interleukin-12 nanoparticles drive a safe and effective response in ovarian tumorsAntonio E Barberio, Sean G Smith, Ivan S Pires, et al.Cell Reports|September 20, 2023
Replication stress and defective checkpoints make fallopian tube epithelial cells putative drivers of high-grade serous ovarian cancerPamoda Galhenage, Yunlan Zhou, Erica Perry, et al.Cancer Discovery|November 7, 2020
Genetically Defined, Syngeneic Organoid Platform for Developing Combination Therapies for Ovarian CancerShuang Zhang, Sonia Iyer, Hao Ran, et al.Pageof 3